135
Peter Thiel, the billionaire tech investor and co-founder of PayPal and Palantir, is part of an investor group that holds a 7.5% stake in 180 Life Sciences, which is rebranding as ETHZilla, an Ethereum-focused corporate treasury vehicle, according to a new SEC disclosure. Shares of 180 Life Sciences (ATNF) jumped over 11% at Monday’s close and surged roughly 57% in overnight trading, Yahoo Finance data shows. 180 Life Sciences announced its Ethereum treasury plan in late July.
On Monday, the biotech firm said it sold $156 millionin senior secured convertible notes due 2028 to an institutional investor, following a recent $425 million private placement. Proceeds will primarily fund Ethereum purchases, yield-bearing assets, and the company’s iGaming operations, while monetizing legacy biotech IP. Thiel’s investor group now has stakes in two Ethereum treasury companies. In mid-July, he reported holding over 9% of Tom Lee’s BitMine Immersion, currently the biggest corporate ETH holder with close to $5 billion in its treasury.
You Might Be Interested In
- Cantor Fitzgerald Launches Bitcoin Lending
- Trump’s Media Company Partners with Crypto.com to Launch ‘Made in America’ ETFs of Digital Assets and Stocks
- Trump’s World Liberty Financial Buys $10M of ETH, LINK & AAVE
- Tether’s $10 Billion Profit So Far in 2025 Competes With Major Banks
- Bitcoin Drops Below $80K as Recent Buyers Realize Losses But Market Indicators Suggest Stability
- BNB Hits All-Time High at $880 Amid Supply Squeeze and Ecosystem Boom























































































































































